Form 4: Castellum COO Merriman Granted 275,000 Stock Options
Insider Transaction Report
Castellum, Inc. Chief Operating Officer Andrew Merriman was granted 275,000 stock options with an exercise price of $1.19, vesting over twenty months.
Summary
- Andrew Merriman, Chief Operating Officer of Castellum, Inc. (CTM), reported a change in beneficial ownership.
- On November 11, 2025, Merriman was granted 275,000 stock options.
- These options have an exercise price of $1.19 per share.
- The options vest ratably over twenty months, commencing December 1, 2025.
- The expiration date for these options is November 10, 2032.
- The grant is in connection with his continued employment and is issued under the Castellum, Inc. Second Amended 2021 Stock Incentive Plan.
Sentiment
Score: 7
Explanation: The grant of stock options to a key executive is generally a positive signal, indicating management retention and alignment of interests, though it also implies potential future dilution.
Positives
- The grant of stock options to the Chief Operating Officer aligns management incentives with shareholder interests.
- The options are part of a structured stock incentive plan, indicating a formal approach to executive compensation.
Risks
- Potential dilution for existing shareholders if all 275,000 options are exercised in the future.
- The value of the options is dependent on the future stock price performance of Castellum, Inc.
Future Outlook
The grant of stock options suggests a long-term commitment from the Chief Operating Officer, aligning his financial interests with the company's future performance and growth.
Industry Context
Executive stock option grants are a common practice in publicly traded companies across various industries to incentivize performance and retain key personnel, aligning with standard compensation practices.
Comparison to Industry Standards
- The use of stock options for executive compensation is a standard practice, comparable to similar incentive plans at companies in the government contracting and technology sectors, such as Palantir Technologies (PLTR) or CACI International (CACI), where equity grants are common for retaining talent and aligning interests.
- The vesting schedule (ratably over twenty months) is a typical mechanism to encourage long-term employment and performance, similar to vesting schedules seen in many tech and defense contractors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan | Stock options were issued pursuant to the Castellum, Inc. Second Amended 2021 Stock Incentive Plan. | N/A (plan already in effect) | Reinforces the executive compensation structure and aligns management incentives with shareholder value creation. |
Stakeholder Impact
- Shareholders: Potential future dilution if options are exercised, but also potential benefit from incentivized management performance.
- Employees: May signal a stable management team and a commitment to executive retention.
Next Steps
- Monitoring the vesting schedule of the options commencing December 1, 2025.
- Observing any future Form 4 filings related to the exercise or sale of these options.
Key Dates
| Date | Description |
|---|---|
| 11/11/2025 | Date of stock option grant to Andrew Merriman. |
| 12/01/2025 | Commencement date for the ratable vesting of stock options. |
| 11/13/2025 | Date the Form 4 was signed by Andrew Merriman. |
| 11/10/2032 | Expiration date of the granted stock options. |
Keywords
Castellum Inc., CTM, Stock Options, Andrew Merriman, COO, Executive Compensation, SEC Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.